Pathogen diversity and adaptation to the host: Applications to clinical genomics

Future Microbiology

Volumn 2, Issue 3, 2007, Pages 215-218

  Waterman, Scott R ^a   Williamson, Peter R ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEIN; COPPER; COPPER REGULATOR 1; COPPER TRANSPORTER 4; CYTOCHROME P450; DNA; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; REGULATOR PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

BRAIN INFECTION; CANDIDA ALBICANS; CLINICAL RESEARCH; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE SEVERITY; DNA MICROARRAY; EDITORIAL; EPIDEMIC; EVOLUTIONARY ADAPTATION; FUNGAL STRAIN; FUNGAL VIRULENCE; GENE EXPRESSION; GENETIC RECOMBINATION; GENETIC TRAIT; GENETIC VARIABILITY; GENOMICS; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENCE; INFECTION RISK; LISTERIA MONOCYTOGENES; MENINGOENCEPHALITIS; METABOLOMICS; MOLECULAR EVOLUTION; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; MYCOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEOMICS; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADAPTATION, PHYSIOLOGICAL; BACTERIA; COMMUNICABLE DISEASES; FUNGI; GENOMICS; HUMANS; VARIATION (GENETICS); VIRULENCE;

EID: 34547494575     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.2.3.215     Document Type: Editorial

References (25)

1. Odds F, Davidson A, Jacobsen M et al.: Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing. J. Clin. Mirobiol. 44, 3647-3658 (2006).
2. Altshuler D, Clark A: Harvesting medical information from the human tree. Science 18, 1052-1053 (2005).
3. Kotzsch M, Farthmann J, Meye A et al.: Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. Eur. J. Cancer 41, 2760-2768 (2005).
4. Hieronymus H, Lamb J, Ross K et al.: Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell 10, 321-330 (2006).
5. Takahashi Y, Miyoshi Y, Morimoto K, Taguchi T. Tamaki Y, Noguchi S: Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers. J. Cancer Res. Clin. Oncol. (2007) (In Press).
6. Kolpakov F, Poroikov V, Sharipov R et al.: CYCLONET - an integrated database on cell cycle regulation and carcinogenesis. Nucleic Acid Res. 35. D550-D556 (2007).
7. Brindie J, Antti H, Holmes E et al.: Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics. Nat. Med. 8, 1439-1444 (2002).
8. Chayakulkeeree M, Perfect J: Cryptococcosis. Infect. Dis. Clin. North Am. 20, 507-544 (2006).
9. Feldmesser M, Kress Y, Novikoff P, Casadevall A: Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68, 4225-4237 (2000).
10. Panepinto J. Williamson P: Intersection of fungal fitness and virulence in Cryptococcus neoformans. FEMS Yeast Res. 6, 489-498 (2006).
11. + oxidation modulate copper toxicity in Saccharomyces cerevisiae. J. Biol. Chem. 278, 50309-50315 (2003).
12. Francis M, Thomas C: The Listeria monocytogenes gene cipA codes a putative P-type ATPase involved in copper transport. Mol. Gen. Genet. 253, 484-491 (1997).
13. Agranoff D, Krishna S: Metal ion homeostasis and intracellular parasitism. Mol. Microbiol. 28, 403-412 (1998).
14. Wagner D, Maser J. Moric I et al.: Changes of the phagosomal elemental concentrations by Mycobacterium tuberculosis. Microbiology 151, 323-332 (2005).
15. Waterman S, Hacham M, Hu G et al.: Role of a CUF1-CTR4 copper regulatory axis in the virulence of Cryptococcus neoformans. J. Clin. Invest. 117, 794-802 (2007).
16. Arnold C: Molecular evolution of Mycobacterium tuberculosis. Clin. Microbiol. Infect. 13, 120-128 (2007).
17. Steenbergen JN, Shuman HA, Casadevall A: Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl Acad. Sci. USA 98, 15245-15250 (2001).
18. McClelland EE, Perrine WT, Potts WK, Casadevall A: Relationship of virulence factor expression to evolved virulence in mouse-passaged Cryptococcus neoformans lines. Infect. Immun. 73, 7047-7050 (2005).
19. Lin X, Huang J, Mitchell T, Heitman J: Virulence attributes and hyphal growth of C. neoformans are quantitative traits and the MATα allele enhances filamentation. PLos Genet. 2, e187 (2006).
20. Jean SS, Fang CT, Shau WY et al.: Cryptococcaemia: clinical features and prognostic factors. QJM 95, 511-518 (2002).
21. Copson P: Super bugs. Br. Dent. J. 196, 248 (2004).
22. Kidd SE, Hagen F, Tscharke RL et al.: A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc. Natl Acad. Sci. USA 101, 17258-17263 (2004).
23. Fraser JA, Giles SS, Wenink EC et al.: Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature 437, 1360-1364 (2005).
24. Bell J: Predicting disease using genomics. Nature 429, 453-456 (2004).
25. Van J: Gene drugs languish in waiting room. Chicago Tribune, August 17, 2006